Literature DB >> 15000845

Preparation and characterization of monoclonal antibody against protein tyrosine phosphatase PRL-3.

Lirong Peng1, Yan Li, Ling Meng, Chengchao Shou.   

Abstract

PRL-3 is a newly identified nonclassical protein tyrosine phosphatase associated with colorectal cancer metastasis. To prepare specific monoclonal antibody (MAb) against PRL-3, cDNAs of PRL-1, -2, and -3 were cloned by RT-PCR and inserted into prokaryotic expression vector pGEX-4T1, respectively. The fusion proteins were expressed in Escherichia coli. Monoclonal antibody against PRL-3 was obtained with hybridoma technique and specific ELISA screening. Western blotting and immunohistochemistry assays showed that MAb 3B6 had specific binding ability with PRL-3 protein in eukaryotic cells. This MAb will be a helpful tool for the detection of PRL-3 protein in the tissues and serum of colorectal cancer and other cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000845     DOI: 10.1089/153685904322771999

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  7 in total

1.  High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.

Authors:  U A Miskad; S Semba; H Kato; Y Matsukawa; Y Kodama; E Mizuuchi; N Maeda; K Yanagihara; H Yokozaki
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

2.  Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer.

Authors:  Ni Dai; Ai-Ping Lu; Cheng-Chao Shou; Ji-You Li
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

3.  Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.

Authors:  Ying Wang; Zhao-Fa Li; Jin He; Yi-Lei Li; Gui-Bin Zhu; Li-Hong Zhang; Yu-Lin Li
Journal:  Int J Colorectal Dis       Date:  2007-04-18       Impact factor: 2.571

4.  Prognostic significance of phosphatase of regenerating liver-3 expression in ovarian cancer.

Authors:  Tingting Ren; Beihai Jiang; Xiaofang Xing; Bin Dong; Lirong Peng; Lin Meng; Huiyu Xu; Chengchao Shou
Journal:  Pathol Oncol Res       Date:  2009-02-27       Impact factor: 3.201

5.  Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma.

Authors:  Xiaofang Xing; Shenyi Lian; Ying Hu; Ziyu Li; Lianhai Zhang; Xianzi Wen; Hong Du; Yongning Jia; Zhixue Zheng; Lin Meng; Chengchao Shou; Jiafu Ji
Journal:  J Transl Med       Date:  2013-12-13       Impact factor: 5.531

6.  PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer.

Authors:  Shenyi Lian; Lin Meng; Xiaofang Xing; Yongyong Yang; Like Qu; Chengchao Shou
Journal:  Oncol Lett       Date:  2016-07-11       Impact factor: 2.967

7.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.